Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Biosimilars"

The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market

Richard Quinn  |  March 17, 2015

With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases

Update on Legislation, Advocacy Efforts to Advance Rheumatology

Joseph Flood, MD  |  September 1, 2014

Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

EULAR 2014: Biosimilar Drug Production Raises Concerns

Thomas R. Collins  |  August 1, 2014

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

Rheumatology Advocacy Starts at Home

Joseph Flood, MD  |  August 1, 2014

The ACR expands advocacy efforts to impact state legislatures, local organizations

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Why Tweaking Molecular Structures Can Be Hazardous to Our Health

Simon M. Helfgott, MD  |  June 1, 2014

The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development

Update on Healthcare Reform in 2014 under the Affordable Care Act

Joseph Flood, MD, & Kam Nola, PharmD, MS  |  June 1, 2014

The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

When Will Generic Biologic Drugs Become Commercially Available?

Vibke Strand, MD, and Richard Brasington, MD  |  August 1, 2013

Biosimilars are challenging to produce, but progress is being made

  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences